Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,175
Closed -$205K 565
2025
Q3
$205K Sell
4,175
-297
-7% -$15.2K 0.01% 497
2025
Q2
$231K Buy
4,472
+41
+0.9% +$1.88K 0.02% 449
2025
Q1
$207K Buy
4,431
+32
+0.7% +$1.65K 0.02% 443
2024
Q4
$225K Buy
+4,399
New +$228K 0.02% 389
2024
Q2
Sell
-7,223
Closed -$289K 461
2024
Q1
$289K Sell
7,223
-81
-1% -$3.04K 0.03% 288
2023
Q4
$275K Buy
7,304
+51
+0.7% +$1.56K 0.03% 268
2023
Q3
$202K Sell
7,253
-404
-5% -$12.6K 0.03% 302
2023
Q2
$232K Buy
7,657
+17
+0.2% +$497 0.03% 287
2023
Q1
$236K Buy
7,640
+173
+2% +$6.59K 0.03% 266
2022
Q4
$280K Buy
7,467
+791
+12% +$31.4K 0.04% 227
2022
Q3
$250K Hold
6,676
0.04% 204
2022
Q2
$281K Buy
6,676
+20
+0.3% +$827 0.04% 209
2022
Q1
$326K Buy
6,656
+19
+0.3% +$962 0.05% 194
2021
Q4
$318K Buy
6,637
+88
+1% +$4.17K 0.04% 204
2021
Q3
$287K Buy
6,549
+21
+0.3% +$888 0.04% 201
2021
Q2
$286K Buy
6,528
+105
+2% +$4.93K 0.03% 205
2021
Q1
$294K Sell
6,423
-19,046
-75% -$798K 0.03% 205
2020
Q4
$824K Buy
25,469
+339
+1% +$9.81K 0.07% 123
2020
Q3
$532K Buy
25,130
+3,760
+18% +$78.3K 0.05% 134
2020
Q2
$439K Buy
+21,370
New +$413K 0.05% 132
2018
Q4
Sell
-4,768
Closed -$218K 227
2018
Q3
$218K Sell
4,768
-1,273
-21% -$64.1K 0.03% 178
2018
Q2
$319K Buy
6,041
+30
+0.5% +$1.59K 0.04% 129
2018
Q1
$300K Buy
6,011
+19
+0.3% +$957 0.04% 126
2017
Q4
$287K Sell
5,992
-290
-5% -$13.7K 0.04% 140
2017
Q3
$289K Buy
6,282
+20
+0.3% +$867 0.04% 133
2017
Q2
$277K Buy
6,262
+501
+9% +$21.1K 0.06% 132
2017
Q1
$236K Buy
5,761
+17
+0.3% +$709 0.05% 143
2016
Q4
$236K Buy
+5,744
New +$211K 0.05% 137

Other funds holding SNV

Keel Point's SNV Position: Q4 2025 in Review

Keel Point sold out of Synovus (SNV) in Q4 2025, closing a stake of 4,175 shares — an estimated $205K sold.

Keel Point first reported a position in SNV in Q4 2016 and held it in 28 quarters. The position peaked at $824K in Q4 2020. 452 funds tracked by Wall St. Rank hold SNV as of Q4 2025.

  • Keel Point reported no remaining Synovus position as of Q4 2025 after selling out during the quarter.
  • Keel Point sold 4,175 Synovus shares in Q4 2025, an estimated $205K.
  • Keel Point first reported a position in Synovus in Q4 2016 and held it in 28 quarters.
  • Keel Point's Synovus position peaked at $824K in Q4 2020.
  • 452 funds tracked by Wall St. Rank held Synovus as of Q4 2025.

Based on Keel Point's 13F filing for Q4 2025, filed 12 Feb 2026.